Lateral Hypothalamic Orexin/hypocretin Neurons That Project to Ventral Tegmental Area Are Differentially Activated with Morphine Preference

Overview

Journal J Neurosci

Specialty Neurology

Date 2012 Mar 17

PMID 22423101

Citations 37

Authors

Kimberlei A Richardson

Gary Aston-Jones

Affiliations

Soon will be listed here.

Abstract

Orexin (or hypocretin) is synthesized exclusively in dorsomedial, perifornical, and lateral hypothalamus (LH). These neurons are implicated in several functions, including reward processing. We examined the ventral tegmental area (VTA) as a possible site of orexin action for drug preference during protracted morphine abstinence, and studied functional topography of orexin projections to VTA. Male Sprague Dawley rats were used to investigate whether orexin cells that project to VTA exhibit Fos activation with morphine conditioned place preference (CPP), and whether these cells exhibit increased Fos with morphine CPP during protracted abstinence. Unilateral injections of a retrograde tracer (WGA-Au, 350-400 nl) were made into the VTA or a nonreward area, locus ceruleus, and morphine or placebo pellets were implanted for 14 d. Approximately 2 weeks after pellet removal (post dependence), CPP conditioning and testing were conducted. Triple labeling for WGA-Au, Fos, and orexin revealed that the percentage of VTA-projecting orexin neurons Fos activated on the CPP test day significantly increased in post-dependent (vs nondependent) rats, and was exclusive to LH orexin neurons (not dorsomedial or perifornical). Post-dependent animals showed a positive correlation between CPP scores and percentages of Fos-activated, caudal VTA-projecting LH orexin cells. Unlike afferents to caudal VTA, percentages of rostral VTA-projecting, LH orexin cells that were Fos activated showed a positive correlation with CPP only in nondependent animals. Fos in LC-projecting orexin cells was not correlated with CPP in any group. These results indicate that VTA is a heterogeneous and functionally significant target of orexin neurons for morphine reward during protracted abstinence.

Citing Articles

Modelling orexinergic system in ageing in the African turquoise killifish.

Raggio M, Conte I, de Girolamo P, DAngelo L Biogerontology. 2025; 26(2):72.

PMID: 40085285 DOI: 10.1007/s10522-025-10214-1.

Hypocretin-1 receptor antagonism improves inhibitory control during the Go/No-Go task in highly motivated, impulsive male mice.

Metha J, Ji Y, Braun C, Nicholson J, De Lecea L, Murawski C Psychopharmacology (Berl). 2024; 241(10):2171-2187.

PMID: 38886189 PMC: 11442560. DOI: 10.1007/s00213-024-06628-3.

Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation.

Beckenstrom A, Coloma P, Dawson G, Finlayson A, Malik A, Post A Neurosci Biobehav Rev. 2023; 147:105107.

PMID: 36828161 PMC: 10165155. DOI: 10.1016/j.neubiorev.2023.105107.

Paired-pulse Inhibition and Disinhibition of the Dentate Gyrus Following Orexin Receptors Inactivation in the Basolateral Amygdala.

Akbari E, Hosseinmardi N, Rouhi Ardeshiri M Basic Clin Neurosci. 2022; 12(6):827-836.

PMID: 35693145 PMC: 9168815. DOI: 10.32598/bcn.12.6.1460.1.

Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone.

Katzman M, Katzman M Brain Sci. 2022; 12(2).

PMID: 35203914 PMC: 8870430. DOI: 10.3390/brainsci12020150.

References

Harris G, Wimmer M, Aston-Jones G . A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005; 437(7058):556-9. DOI: 10.1038/nature04071. View

Olson V, Zabetian C, Bolanos C, Edwards S, Barrot M, Eisch A . Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci. 2005; 25(23):5553-62. PMC: 6724971. DOI: 10.1523/JNEUROSCI.0345-05.2005. View

Lawrence A . Regulation of alcohol-seeking by orexin (hypocretin) neurons. Brain Res. 2009; 1314:124-9. DOI: 10.1016/j.brainres.2009.07.072. View

Harris G, Aston-Jones G . Arousal and reward: a dichotomy in orexin function. Trends Neurosci. 2006; 29(10):571-7. DOI: 10.1016/j.tins.2006.08.002. View

Nader K, van der Kooy D . Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci. 1997; 17(1):383-90. PMC: 6793678. View

GOLD L, Stinus L, Inturrisi C, Koob G . Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol. 1994; 253(1-2):45-51. DOI: 10.1016/0014-2999(94)90755-2. View

de Lecea L, Kilduff T, Peyron C, Gao X, Foye P, Danielson P . The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998; 95(1):322-7. PMC: 18213. DOI: 10.1073/pnas.95.1.322. View

Harris G, Aston-Jones G . Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal. Behav Brain Res. 2006; 176(2):251-8. PMC: 1809796. DOI: 10.1016/j.bbr.2006.10.012. View

Smith R, See R, Aston-Jones G . Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur J Neurosci. 2009; 30(3):493-503. PMC: 2771107. DOI: 10.1111/j.1460-9568.2009.06844.x. View

10.

Aston-Jones G, Smith R, Sartor G, Moorman D, Massi L, Tahsili-Fahadan P . Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res. 2009; 1314:74-90. PMC: 2819557. DOI: 10.1016/j.brainres.2009.09.106. View

11.

Borgland S, Chang S, Bowers M, Thompson J, Vittoz N, Floresco S . Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci. 2009; 29(36):11215-25. PMC: 2771749. DOI: 10.1523/JNEUROSCI.6096-08.2009. View

12.

Espana R, Oleson E, Locke J, Brookshire B, Roberts D, Jones S . The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci. 2009; 31(2):336-48. PMC: 2881680. DOI: 10.1111/j.1460-9568.2009.07065.x. View

13.

Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M . Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 2000; 873(1):181-7. DOI: 10.1016/s0006-8993(00)02555-5. View

14.

Vittoz N, Berridge C . Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology. 2005; 31(2):384-95. DOI: 10.1038/sj.npp.1300807. View

15.

Mahler S, Smith R, Aston-Jones G . Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl). 2012; 226(4):687-98. PMC: 3649073. DOI: 10.1007/s00213-012-2681-5. View

16.

Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli R, Tanaka H . Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998; 92(5):1 page following 696. DOI: 10.1016/s0092-8674(02)09256-5. View

17.

Aston-Jones G, Harris G . Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology. 2004; 47 Suppl 1:167-79. DOI: 10.1016/j.neuropharm.2004.06.020. View

18.

Gompf H, Aston-Jones G . Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res. 2008; 1224:43-52. PMC: 2596878. DOI: 10.1016/j.brainres.2008.05.060. View

19.

Delfs J, Zhu Y, Druhan J, Aston-Jones G . Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature. 2000; 403(6768):430-4. DOI: 10.1038/35000212. View

20.

Bassareo V, Tanda G, Di Chiara G . Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berl). 1995; 122(2):202-5. DOI: 10.1007/BF02246097. View